Ensuring safety and efficacy through the vaccine pipeline

Every vaccine starts its journey years before the first public dose: scientists assess whether the vaccine produces protective antibodies without undue harm. Only after the national regulator’s approval does it enter the markets and immunisation programmes. And the watch never ends: doctors and healthcare workers report any event occurring after vaccination